Men's Health Latest News
Risk of being admitted for non-cancer conditions is 38% higher in the year after a PCa diagnosis compared with a year before.
The advice is useful as clinicians wait for formal guidelines.
Ablating only the prostate lobe with the tumor resulted in satisfactory mid-term functional outcomes, researchers reported.
Prostatic arterial embolization significantly reduced volumes of median lobes, central zones, peripheral zones, and whole prostate glands.
Patient age and tumor risk may be more strongly associated with use of expectant management for veterans with low-risk prostate cancer.
Antibiotics selected based on results of pre-biopsy rectal swab cultures.
Combination angiogenesis inhibition can be safely administered with supportive measures in metastatic castration-resistant prostate cancer (mCRPC).
Combined radiotherapy remains controversial due to the increased potential for toxicities.
Any baldness is associated with a 56% higher risk of dying from the malignancy.
Men receiving common medical treatments for LUTS/BPH, including phytotherapy, experienced similar symptom relief.
Many men are unaware of erectile function recovery time and problems with ejaculation.
Prostate cancer is 1.4 times more likely to develop in those with a PSA level of 2.5 ng/mL or higher.
Enzalutamide reduced the risk of disease progression by 56% in mCRPC patients.
A newly developed profiling method may be helpful in the management of patients with high-risk prostate cancer.
A combination of exercise and a flavonoid-rich diet can reduce the risk of erectile dysfunction by 21%.
Men's Health Videos
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)